Peter Alarcon Manchego MD (is Director for Pediatric Value, Office of Quality and Safety, NYC Health + Hospitals, New York, and Pediatrician, Kings County Hospital, Brooklyn, New York.), Mona Krouss MD (formerly Assistant Vice President of Value and Patient Safety, NYC Health + Hospitals, is Chief of Hospital Medicine and Director of Inpatient Quality, James J. Peters VA [US Department of Veterans Affairs] Medical Center, Bronx, New York, and Associate Clinical Professor, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York.), Daniel Alaiev (formerly Director of Outcomes and Biostatistics, NYC Health + Hospitals, is Medical Student, Perelman School of Medicine, University of Pennsylvania.), Joseph Talledo MS (is Data Analyst, Office of Quality and Safety, NYC Health + Hospitals.), Surafel Tsega MD (is Hospitalist, NYC Health + Hospitals/King's County, and Assistant Clinical Professor, Department of Medicine, Icahn School of Medicine at Mount Sinai.), Komal Chandra PhD (is Director of Operations for Patient Safety and High Value Care, NYC Health + Hospitals.), Milana Zaurova M (is Director of Quality, Equity, and Palliative Care, Office of Quality and Safety, NYC Health + Hospitals, and Assistant Professor, Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai.), Dawi Shin (is Medical Student, Icahn School of Medicine at Mount Sinai.), Victor Cohen PharmD (is Assistant Vice President, Pharmacy Services, NYC Health + Hospitals.), Hyung J Cho MD (is Internist. and Vice President of Quality, Department of Quality and Safety, Brigham and Women's Hospital, Boston. Please address correspondence to Peter Alacon Manchego)
{"title":"Using a Built-in Clinical Decision Support to Improve Phosphate Repletion Practice: A Quasi-Experimental Study","authors":"Peter Alarcon Manchego MD (is Director for Pediatric Value, Office of Quality and Safety, NYC Health + Hospitals, New York, and Pediatrician, Kings County Hospital, Brooklyn, New York.), Mona Krouss MD (formerly Assistant Vice President of Value and Patient Safety, NYC Health + Hospitals, is Chief of Hospital Medicine and Director of Inpatient Quality, James J. Peters VA [US Department of Veterans Affairs] Medical Center, Bronx, New York, and Associate Clinical Professor, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York.), Daniel Alaiev (formerly Director of Outcomes and Biostatistics, NYC Health + Hospitals, is Medical Student, Perelman School of Medicine, University of Pennsylvania.), Joseph Talledo MS (is Data Analyst, Office of Quality and Safety, NYC Health + Hospitals.), Surafel Tsega MD (is Hospitalist, NYC Health + Hospitals/King's County, and Assistant Clinical Professor, Department of Medicine, Icahn School of Medicine at Mount Sinai.), Komal Chandra PhD (is Director of Operations for Patient Safety and High Value Care, NYC Health + Hospitals.), Milana Zaurova M (is Director of Quality, Equity, and Palliative Care, Office of Quality and Safety, NYC Health + Hospitals, and Assistant Professor, Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai.), Dawi Shin (is Medical Student, Icahn School of Medicine at Mount Sinai.), Victor Cohen PharmD (is Assistant Vice President, Pharmacy Services, NYC Health + Hospitals.), Hyung J Cho MD (is Internist. and Vice President of Quality, Department of Quality and Safety, Brigham and Women's Hospital, Boston. Please address correspondence to Peter Alacon Manchego)","doi":"10.1016/j.jcjq.2024.07.009","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Inpatient serum phosphate replacement is common, but there is great variability in replacement practice, which leads to overuse. Electronic health record (EHR) interventions with clinical decision support (CDS) can be effective tools to guide clinicians toward best clinical practices. The authors’ objective was to use CDS tools to reduce overuse of hypophosphatemia corrections at a large safety-net health care system.</div></div><div><h3>Methods</h3><div>The first intervention involved enhancing an existing order set for phosphate repletion by incorporating CDS to guide appropriate repletion orders based on deficit severity and simplifying ordering. The second intervention was a Best Practice Advisory (BPA) that triggered when an intravenous (IV) phosphate repletion was ordered for a patient with mild to moderate phosphate deficiency without an existing nil per os (NPO) order. The primary outcome measure was the number of patients with mild and moderate hypophosphatemia receiving IV replacement without NPO orders per 1,000 patient-days.</div></div><div><h3>Results</h3><div>Across all hospitals, rate of IV replacement in patients with mild to moderate hypophosphatemia (1.0 to 1.9 mg/dL) without NPO orders decreased from 7.22 to 3.40 per 1,000 patient-days (53.0% reduction, <em>p</em> < 0.001), while the oral replacements in this population increased from 6.39 to 8.87 (38.8% increase, <em>p</em> < 0.001). For patients with phosphate levels ≥ 2.0, IV replacements decreased from 10.66 to 5.36 (49.8% reduction, <em>p</em> < 0.001), and oral replacements from decreased 19.78 to 16.69 (15.6% reduction, <em>p</em> < 0.01).</div></div><div><h3>Conclusion</h3><div>This intervention successfully reduced inpatient IV phosphate replacements by 53.0% in patients with mild to moderate hypophosphatemia using a two-pronged EHR intervention across a large safety-net setting.</div></div>","PeriodicalId":14835,"journal":{"name":"Joint Commission journal on quality and patient safety","volume":"50 11","pages":"Pages 801-808"},"PeriodicalIF":2.3000,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Joint Commission journal on quality and patient safety","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1553725024002319","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Inpatient serum phosphate replacement is common, but there is great variability in replacement practice, which leads to overuse. Electronic health record (EHR) interventions with clinical decision support (CDS) can be effective tools to guide clinicians toward best clinical practices. The authors’ objective was to use CDS tools to reduce overuse of hypophosphatemia corrections at a large safety-net health care system.
Methods
The first intervention involved enhancing an existing order set for phosphate repletion by incorporating CDS to guide appropriate repletion orders based on deficit severity and simplifying ordering. The second intervention was a Best Practice Advisory (BPA) that triggered when an intravenous (IV) phosphate repletion was ordered for a patient with mild to moderate phosphate deficiency without an existing nil per os (NPO) order. The primary outcome measure was the number of patients with mild and moderate hypophosphatemia receiving IV replacement without NPO orders per 1,000 patient-days.
Results
Across all hospitals, rate of IV replacement in patients with mild to moderate hypophosphatemia (1.0 to 1.9 mg/dL) without NPO orders decreased from 7.22 to 3.40 per 1,000 patient-days (53.0% reduction, p < 0.001), while the oral replacements in this population increased from 6.39 to 8.87 (38.8% increase, p < 0.001). For patients with phosphate levels ≥ 2.0, IV replacements decreased from 10.66 to 5.36 (49.8% reduction, p < 0.001), and oral replacements from decreased 19.78 to 16.69 (15.6% reduction, p < 0.01).
Conclusion
This intervention successfully reduced inpatient IV phosphate replacements by 53.0% in patients with mild to moderate hypophosphatemia using a two-pronged EHR intervention across a large safety-net setting.